Atlas Trials

A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients

Clinical trial NCT02035020 · COMPLETED

Trial details

NCT number
NCT02035020
Sponsor
Azienda Policlinico Umberto I
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Friedreich Ataxia
Start date
2013-05-01
Primary completion
2014-07-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.